297 related articles for article (PubMed ID: 17307198)
1. Clonal diversification in OspA-specific antibodies from peripheral circulation of a chronic Lyme arthritis patient.
Ghosh S; Huber BT
J Immunol Methods; 2007 Apr; 321(1-2):121-34. PubMed ID: 17307198
[TBL] [Abstract][Full Text] [Related]
2. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
Izac JR; Oliver LD; Earnhart CG; Marconi RT
Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato.
Drouin EE; Glickstein LJ; Steere AC
J Autoimmun; 2004 Nov; 23(3):281-92. PubMed ID: 15501399
[TBL] [Abstract][Full Text] [Related]
5. Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions.
Shandilya S; Kurt Yilmaz N; Sadowski A; Monir E; Schiller ZA; Thomas WD; Klempner MS; Schiffer CA; Wang Y
J Mol Recognit; 2017 May; 30(5):. PubMed ID: 27859766
[TBL] [Abstract][Full Text] [Related]
6. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.
Liang FT; Caimano MJ; Radolf JD; Fikrig E
Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158
[TBL] [Abstract][Full Text] [Related]
7. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
Eschner AK; Mugnai K
Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
[TBL] [Abstract][Full Text] [Related]
8. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
[TBL] [Abstract][Full Text] [Related]
9. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
[TBL] [Abstract][Full Text] [Related]
10. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
Wagner B; Freer H; Rollins A; Erb HN
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
[TBL] [Abstract][Full Text] [Related]
11. Characterization and optimization of a novel vaccine for protection against Lyme borreliosis.
Comstedt P; Hanner M; Schüler W; Meinke A; Schlegl R; Lundberg U
Vaccine; 2015 Nov; 33(44):5982-8. PubMed ID: 26277070
[TBL] [Abstract][Full Text] [Related]
12. Serum reactivity against Borrelia burgdorferi OspA in patients with rheumatoid arthritis.
Hsieh YF; Liu HW; Hsu TC; Wei JC; Shih CM; Krause PJ; Tsay GJ
Clin Vaccine Immunol; 2007 Nov; 14(11):1437-41. PubMed ID: 17881508
[TBL] [Abstract][Full Text] [Related]
13. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
Zhong W; Gern L; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
[TBL] [Abstract][Full Text] [Related]
14. Infection of mice with lyme disease spirochetes constitutively producing outer surface proteins a and B.
Strother KO; Hodzic E; Barthold SW; de Silva AM
Infect Immun; 2007 Jun; 75(6):2786-94. PubMed ID: 17371860
[TBL] [Abstract][Full Text] [Related]
15. NMR identification of epitopes of Lyme disease antigen OspA to monoclonal antibodies.
Huang X; Yang X; Luft BJ; Koide S
J Mol Biol; 1998 Aug; 281(1):61-7. PubMed ID: 9680475
[TBL] [Abstract][Full Text] [Related]
16. Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector.
Battisti JM; Bono JL; Rosa PA; Schrumpf ME; Schwan TG; Policastro PF
Infect Immun; 2008 Nov; 76(11):5228-37. PubMed ID: 18779341
[TBL] [Abstract][Full Text] [Related]
17. Structure of a transmission blocking antibody in complex with Outer surface protein A from the Lyme disease spirochete, Borreliella burgdorferi.
Rudolph MJ; Davis SA; Haque HME; Ejemel M; Cavacini LA; Vance DJ; Willsey GG; Piazza CL; Weis DD; Wang Y; Mantis NJ
Proteins; 2023 Nov; 91(11):1463-1470. PubMed ID: 37455569
[TBL] [Abstract][Full Text] [Related]
18. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
Lovrich SD; Jobe DA; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
[TBL] [Abstract][Full Text] [Related]
19. The Lyme disease vaccine takes its toll.
Thomas V; Fikrig E
Vector Borne Zoonotic Dis; 2002; 2(4):217-22. PubMed ID: 12804162
[TBL] [Abstract][Full Text] [Related]
20. Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.
Meirelles Richer L; Aroso M; Contente-Cuomo T; Ivanova L; Gomes-Solecki M
Clin Vaccine Immunol; 2011 Nov; 18(11):1809-16. PubMed ID: 21918116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
